Clinical Trial Update: The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of a GLP-1 receptor agonist on psoriasis. The study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Annesofie Faurschou | Conditions: Psoriasis | NA | Status: COMPLETED